Structure Therapeutics (GPCR) Return on Assets (2023 - 2026)

Quarterly Return on Assets changed 0.0% to 0.0% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.0% through Mar 2026, changed 0.0% year-over-year, with the annual reading at 0.0% for FY2025, 0.0% changed from the prior year.

Structure Therapeutics' Return on Assets history spans 4 years, with the latest figure at 0.0% for Q1 2026.

  • Return on Assets came in at 0.0% for Q1 2026, down from 0.0% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.0% in Q4 2025 to a low of 0.0% in Q3 2023.
  • The 4-year median for Return on Assets is 0.0% (2024), against an average of 0.0%.
  • The largest YoY upside for Return on Assets was 0bps in 2024 against a maximum downside of 0bps in 2024.
  • Structure Therapeutics' Return on Assets stood at 0.0% in 2023, then plummeted by -344bps to 0.0% in 2024, then soared by 102bps to 0.0% in 2025, then plummeted by -814bps to 0.0% in 2026.
  • Per Business Quant, the three most recent readings for GPCR's Return on Assets are 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -0.01%
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 0.00%
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -0.01%
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 0.00%
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 0.00%
8 Evaxion A 65.12 Bn 65.10 Bn - 0.00%
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 0.00%
10 Structure Therapeutics 8.43 Bn 8.43 Bn - 0.00%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.00%
Dec 31, 2025 0.00%
Sep 30, 2025 0.00%
Jun 30, 2025 0.00%
Mar 31, 2025 0.00%
Dec 31, 2024 0.00%
Sep 30, 2024 0.00%
Jun 30, 2024 0.00%
Mar 31, 2024 0.00%
Dec 31, 2023 0.00%
Sep 30, 2023 0.00%
Jun 30, 2023 0.00%
Mar 31, 2023 0.00%